EA200000769A1 - Мутанты il-16, способы их производства и их применение - Google Patents
Мутанты il-16, способы их производства и их применениеInfo
- Publication number
- EA200000769A1 EA200000769A1 EA200000769A EA200000769A EA200000769A1 EA 200000769 A1 EA200000769 A1 EA 200000769A1 EA 200000769 A EA200000769 A EA 200000769A EA 200000769 A EA200000769 A EA 200000769A EA 200000769 A1 EA200000769 A1 EA 200000769A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- production
- application
- mutants
- methods
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5446—IL-16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Нуклеиновая кислота, которая может быть использована для экспрессии мутантного IL-16 в прокариотических или эукариотических хозяйских клетках, где упомянутая нуклеиновая кислота кодирует полипептид с аминокислотной последовательностью , начинающейся с аминокислот 1-5 и кончающейся аминокислотами 93-107 последовательности SEQ ID NO:2, и является пригодной для производства мутантного IL-16 с улучшенной активностью.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98101232 | 1998-01-24 | ||
PCT/EP1999/000428 WO1999037781A1 (en) | 1998-01-24 | 1999-01-22 | Mutants of il-16, processes for their production, and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200000769A1 true EA200000769A1 (ru) | 2001-02-26 |
Family
ID=8231307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000769A EA200000769A1 (ru) | 1998-01-24 | 1999-01-22 | Мутанты il-16, способы их производства и их применение |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1049782A1 (ru) |
JP (1) | JP2002500889A (ru) |
AU (1) | AU2424399A (ru) |
BR (1) | BR9907216A (ru) |
CA (1) | CA2320624A1 (ru) |
EA (1) | EA200000769A1 (ru) |
MX (1) | MXPA00006059A (ru) |
WO (1) | WO1999037781A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699466B1 (en) | 1999-08-05 | 2004-03-02 | Research Corporation Technologies, Inc. | IL-16 antagonist peptides and DNA encoding the peptides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028134A1 (en) * | 1993-05-21 | 1994-12-08 | The Trustees Of Boston University | Lymphocyte chemoattractant factor and uses thereof |
CA2239704A1 (en) * | 1995-12-22 | 1997-07-03 | Bundesrepublik Dutschland, Vertreten Durch Den Bundesminister Fur Gesundheit | Polypeptides with interleukin 16 activity, process for the preparation and use thereof |
DE19617202A1 (de) * | 1996-04-30 | 1997-11-06 | Boehringer Mannheim Gmbh | Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung |
US6444202B1 (en) * | 1996-11-25 | 2002-09-03 | Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit | Processed polypeptides with IL-16 activity, processes for their production and their use |
-
1999
- 1999-01-22 JP JP2000528688A patent/JP2002500889A/ja not_active Ceased
- 1999-01-22 MX MXPA00006059A patent/MXPA00006059A/es unknown
- 1999-01-22 CA CA002320624A patent/CA2320624A1/en not_active Abandoned
- 1999-01-22 EA EA200000769A patent/EA200000769A1/ru unknown
- 1999-01-22 AU AU24243/99A patent/AU2424399A/en not_active Abandoned
- 1999-01-22 EP EP99903675A patent/EP1049782A1/en not_active Withdrawn
- 1999-01-22 WO PCT/EP1999/000428 patent/WO1999037781A1/en not_active Application Discontinuation
- 1999-01-22 BR BR9907216-5A patent/BR9907216A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2320624A1 (en) | 1999-07-29 |
WO1999037781A1 (en) | 1999-07-29 |
JP2002500889A (ja) | 2002-01-15 |
BR9907216A (pt) | 2000-10-24 |
EP1049782A1 (en) | 2000-11-08 |
MXPA00006059A (es) | 2003-08-01 |
AU2424399A (en) | 1999-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
ATE342359T1 (de) | Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften | |
ATE293696T1 (de) | Mutierte alpha-amylase enzyme mit erhöhter stabilität | |
AU6329694A (en) | Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase | |
DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
DE59711812D1 (de) | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
FI885679A0 (fi) | Samuttryckning i eukariotiska celler. | |
ATE414775T1 (de) | Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren | |
JPS5648884A (ru) | ||
Shlyapnikov et al. | Primary structure of cytoplasmic aspartate aminotransferase from chicken heart and its homology with pig heart isoenzymes | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
NZ506748A (en) | Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production | |
PT1200561E (pt) | Clone celular recombinante estavel, sua producao e utilizacao | |
DE69735242D1 (de) | N-terminal verlängerte proteine exprimiert in hefe | |
DE69831979D1 (de) | Gefrorenes lebensmittel | |
DK0904356T3 (da) | Aspergillus Oryzae 5-aminolevulinsyre-synthaser og nukleinsyrer, der koder disse | |
EA200000769A1 (ru) | Мутанты il-16, способы их производства и их применение | |
ES2168282T3 (es) | D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion. | |
DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
WO2002008417A1 (fr) | Procede de production d'une proteine de recombinaison | |
DK383984A (da) | Fremgangsmaade til fremstilling af sekretin | |
TR199802168T2 (xx) | IL-16 Aktivitesine sahip işlenmiş polipeptidler, bunları üretmeye mahsus yöntemler ve bunların kullanımı. | |
WO1995021916A3 (en) | Pp32: a newly identified cd45-associated protein | |
WO2000052133A3 (en) | Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same |